USD 40.39 billion
Antibiotics Market Size, Share, Growth Analysis, By Drug Class(Cephalosporin, Penicillin, Fluoroquinolone, Macrolides), By Action Mechanism(Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors), By Type(Branded Antibiotics, Generic Antibiotics), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35B2164 |
Region:
Global |
Published Date: September, 2024
Pages:
165
|Tables:
72
|Figures:
75
Antibiotics Market Insights
Global Antibiotics Market size was valued at USD 50.60 billion in 2022 and is poised to grow from USD 52.67 billion in 2023 to USD 72.65 billion by 2031, growing at a CAGR of 4.10% during the forecast period (2024-2031).
The global market has experienced important innovations, notably advanced pharmaceutical formulations, combination therapies and new mechanisms of action. These innovation trends aim to drive pharmaceutical consumption addressing antibiotic resistance, increasing productivity and adapting to evolving microbial challenges. The companies’ commitment to research and development underscores their commitment to remain at the forefront of infectious disease prevention.
Several players, such as AbbVie, Inc., Pfizer Inc., Novartis AG, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd., have announced acquisitions. Through M&A activity, these companies can expand their geographic reach and enter new territories. Companies are actively investing heavily in clinical trials and regulatory submissions to gain regulatory approval for pipeline products. This increases the cost of developing new antibiotics.
The market has witnessed a remarkable product expansion due to the development of new antimicrobial formulations and combinations. These innovations include advanced antimicrobial efficacy and a broader range of activities addressing the challenge of antimicrobial resistance. The market also sees ongoing research into new strategies and formulations to stay ahead in the development of bacterial strains.
US Antibiotics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Cephalosporin
Fastest Growth
Cephalosporin
Growth Rate
2.5% CAGR
Global Antibiotics Market ($ Bn)
Country Share for Asia Pacific Region (%)
To get more reports on the above market click here to Buy The Report
Antibiotics Market Segmental Analysis
Global Antibiotics Market is segmented by Drug Class, Type, Action Mechanism, and region. Based on Drug Class, the market is segmented into Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, 7-ACA, and Others. Based on Type, the market is segmented into Branded Antibiotics, Generic Antibiotics. Based on Action Mechanism, the market is segmented into Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Antibiotics Market Analysis by Type
The generic antibiotics segment accounted for the largest revenue share in 2023. Affordability of generic formulations, large number of employees leading to high customer bargaining power and supportive regulatory framework are major segment drivers the market. Generic antibiotics are generic drugs that can be obtained when the efficacy of the original antibiotics. These drugs play an important role in facilitating treatments, especially in developing countries where healthcare costs are a major factor. The increasing availability of affordable generics, as they are often less expensive than their branded counterparts, offers the same therapeutic benefits. Equitable use of antibiotics is important for financially constrained health systems, as it helps meet the need for cost-effective treatment. Government and health practitioners often prefer standard drugs to inexpensively manage bacterial infections.
The branded antibiotics segment is estimated to register the highest CAGR from 2024 to 2031 due to robust research pipeline, growing importance of new & innovative antibiotics. The growth focusing key players to strengthen their product offerings & distribution networks in the dense. For example, approval was obtained from the Alembic Drug Administration in February 2023 for fesoterodine fumarate extended-release tablets, 4 mg and 8 mg. These features increase the market demand. Branded antibiotics are first-generation drugs developed and marketed by pharmaceutical companies, usually with patent protection for several years. These drugs usually result from extensive research and development (R&D) efforts and undergo rigorous clinical testing before approval to enter the market. As a result, labeled antibiotics are often more expensive than generic drugs but are critical to driving innovation in the industry.
Analysis by Drug Class
The penicillin segment accounted for the largest revenue share at 23.8% in 2023. Penicillin was the first drug discovered and is still widely used to treat various infections, especially staphylococci and streptococci, clostridium, and listeria by blocking cell walls or blocking peptidoglycan layers. These drugs represent the leading treatment in treating infections such as gum disease, dermatitis, bronchitis, asthma, ear mites etc. during the forecast period. As a public health concern refers to the skin and tropical diseases (NTDs). It is estimated that about 18 million people worldwide are affected by skin diseases at any given time.
Cephalosporins are expected to increase significantly over the forecast period. Cephalosporins are subtypes of antibiotics in the beta-lactam class. These compounds are active against Gram and Gram-negative bacteria such as Pseudomonas aeruginosa, Klebsiella pneumoniae, and Bactericides fragilis. Like the penicillin group, generics dominate the cephalosporins segment and have exhibited consumption. Cephalosporins consist of five generations of medicines with diverse activities. However, the third, fourth and fifth generations of these agents are the most common antibiotics. Cefixime is the third-generation broad-spectrum cephalosporin commonly used to treat infections caused by P. aeruginosa & N. gonorrhea.
Global Antibiotics Market By Drug Class (%)
To get detailed analysis on other segments, Request For Free Sample Report
Antibiotics Market Regional Insights
Asia Pacific dominated the market and accounted for 43.8% of the revenue in the region owing to rise in infectious diseases, rise in dispensing of non-prescription drugs, presence of well-established hospitals & clinics. According to a University of Oslo article published in May 2023, the main suppliers of antibiotics are India and China. Antibiotics and antimicrobial products from both countries are of great importance to the world. China is the world’s leading producer and manufacturer of antibiotics. Similarly, according to a BBC news article published in September 2023, national data shows that out of 29.1% of the 125 million people aged 65 or over, Japan has the lowest fertility rate in the world. Older people are more susceptible to infectious diseases. In addition, the incidence of drug-resistant infectious diseases is increasing, increasing the demand for alternative treatment options.
North America is anticipated to witness giant growth. These markets are notably standardized with improvements in healthcare infrastructure. Regional market growth is driven with the aid of rising incidences of infectious sicknesses, which, in turn, are boosting the demand for new antimicrobial formulations. The growth is also driven by elevated research and development, in addition to through quite a few existing antibiotic stewardship projects. According to a Definitive Healthcare article published in August 2023, the wide variety of antibiotic prescriptions issued by healthcare carriers.
Global Antibiotics Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Antibiotics Market Dynamics
Antibiotics Market Driver
Rising Incidence of Infectious Diseases
- Increasing incidence of infectious diseases across the globe is one of the major drivers of the antibiotics market. Respiratory infections, TB, urinary tract infections, sexually transmitted diseases infections (STDs) are some of the major antibiotic-treated diseases increased in addition to multidrug resistant. With the emergence of strains, health care providers are seeking new, more potent antibiotics to overcome these challenges.
Advances in Antibiotic Development
- Technological advances in drug discovery and microbiological research have led to the development of new antibiotics. Industries are seeking new antibiotics and supplying existing ones have been effective in combating resistance and extending the efficacy of treatments. Precision therapies that support the development of antibodies targeted to specific pathogens are gaining momentum. This growth is driven by increasing investments by pharmaceutical companies and government policies aimed at developing resistant antibiotics. These innovations have the potential to market significant growth in the coming years.
Restraints
Growing Problem of Antibiotic Resistance
- One of the biggest challenges the antibiotics market faces is the growing problem of antibiotic resistance. Overuse and misuse of antibiotics in both humans and livestock have contributed to bacteria becoming resistant to many existing drugs. The World Health Organization (WHO) has classified antimicrobial resistance as one of the top public health threats. As more bacteria become resistant, fewer antibiotics remain effective, making the development of new ones an urgent but difficult task. This resistance limits the use of certain antibiotics, slowing down the overall market expansion and creating a need for significant investment in research.
Stringent Regulations Navigating FDA and EMA Guidelines for Antibiotic Approval
- Developing new antibiotics is not only costly but also involves lengthy regulatory processes. Regulatory bodies like the Food and Drug Administration (FDA) and European Medicines Agency (EMA) have stringent guidelines to ensure the safety and efficacy of antibiotics before they are approved for public use. Meeting these regulatory requirements adds to the time and cost of bringing new antibiotics to market.
Request Free Customization of this report to help us to meet your business objectives.
Antibiotics Market Competitive Landscape
The antibiotics market is a highly competitive and growing environment, with numerous global and regional manufacturers to research, manufacture and sell antibiotics. The key players in the market are large pharmaceutical and small biotech companies focused on meeting the growing demand for effective antibiotics. The competitive landscape is determined by factors such as product innovation, mergers and acquisitions, partnerships and government policies aimed at promoting antibiotic research.
Antibiotics Market Top Player’s Company Profiles
- Pfizer Inc. (US)
- GlaxoSmithKline plc. (GSK) (UK)
- Sanofi S.A. (France)
- Merck & Co., Inc. (US)
- Novartis AG (Switzerland)
- Johnson & Johnson (US)
- F. Hoffmann-La Roche AG (Switzerland)
- AstraZeneca PLC (UK)
- Bayer AG (Germany)
- Abbott Laboratories (US)
- Eli Lilly and Company (US)
- Bristol-Myers Squibb Company (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Astellas Pharma Inc. (Japan)
- Cipla Ltd (India)
- AbbVie, Inc. (US)
- Lupin Pharmaceuticals, Inc. (US)
- Viatris, Inc. (US)
- Melinta Therapeutics LLC (US)
- Cipla, Inc. (US)
- Shionogi & Co., Ltd. (Japan)
- KYORIN Pharmaceutical Co., Ltd. (Japan)
- Nabriva Therapeutics PLC (Ireland)
Antibiotics Market Recent Developments
- In July 2023, Orchid Pharma, a pharmaceutical company based in India, signed a technology transfer agreement with a biotechnology company for its fermentation based on the "7ACA" project, an incentive program for production.
- In April 2023, Baxter International Inc. launched ZOSYN in the US. (piperacillin and tazobactam) Injection.
- In December 2022, a new antimicrobial siderophore cephalosporin, cefiderocol, was approved for clinical trial in Taiwan.
Antibiotics Key Market Trends
- Increased Focus on Narrow-spectrum Antibiotics: A growing trend in the antibiotics market is the shift from broad-spectrum antibodies to narrow-spectrum drugs broad-spectrum antibiotics affect a wide range of bacteria and can cause side effects and lead to resistance. However, narrow-spectrum antibiotics target specific bacterial species, reduce the risk of the resistance, and maintain the balance of healthy bacteria in the body.
- Rise of Antibiotic Stewardship Programs: The rise of antibiotic monitoring applications is turning into increasingly more essential as fitness care companies seek to fight the upward push in antibiotic abuse and resistance. Such programs are aware of the proper use of antibiotics to ensure that they're prescribed in the correct amount when needed. This trend could affect the market by influencing prescribing by encouraging more responsible use of antibiotics.
Antibiotics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to SkyQuest analysis, the antibiotics market is driven by the increasing incidence of infectious diseases, advances in antibiotic development, which has led to the demand for the new and more effective therapies. The rise in drug-resistant bacterial strains has provided urgency the search for new antibiotics has increased, creating important opportunities for growth. Antibiotic resistance and regulatory constraints. Rising bacterial resistance makes it difficult to treat infections with existing antibiotics, and time-consuming regulatory processes can delay the introduction of new drugs. Certification and antibiotic oversight an increasing number of programs, which promote the responsible use of these essential medicines.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 50.60 billion |
| Market size value in 2031 | USD 72.65 billion |
| Growth Rate | 4.10% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Antibiotics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Antibiotics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Antibiotics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Antibiotics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Antibiotics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Antibiotics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
